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Abstract
Mosquitoes transmit pathogens that cause infectious diseases of global importance. Techniques to easily introduce genes
into mosquitoes, however, limit investigations of the interaction between microbes and their arthropod vectors. We now
show that a cationic liposome significantly enhances delivery and expression of plasmid DNA in Aedes aegypti and
Anopheles gambiae mosquitoes. We then introduced the genes for Ae. aegypti thioester-containing proteins (AeTEPs), which
are involved in the control of flaviviral infection, into mosquitoes using this technique. In vivo transfection of AeTEP-1 into
Ae. aegypti significantly reduced dengue virus infection, suggesting that the approach can further our understanding of
pathogen-mosquito interactions.
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Introduction
Mosquitoes transmit pathogens of medical importance through-
out the world. Approximately 700 million people develop
mosquito-borne infectious diseases each year, and more than 2
million individuals die of these illnesses [1]. The ability of
mosquitoes to transmit viruses and protozoa varies widely. Dengue
virus (DENV) and Yellow Fever virus (YFV) are primarily
transmitted by Aedes aegypti [2,3]; West Nile virus (WNV) is carried
by Culex spp. and Aedes spp. [4–6]; and the genus Anopheles is the
dominant vector for Plasmodium spp. [7]. Approved human vaccines
are not yet available for many of these infectious diseases [8]. An
comprehensive understanding of the survival of microbes in
mosquitoes may facilitate the development of new strategies
to control transmission and reduce infection. The limitation of
current approaches to introduce genes into mosquitoes, however,
impairs efforts to investigate the interactions between pathogens
and these important arthropod vectors.
Studies in mosquitoes currently rely on several techniques,
including RNA interference (RNAi) [9] and germline transforma-
tion [10]. RNAi is the most popular approach, and has been
broadly applied to functional studies in mosquitoes [11]. Another
common strategy is to produce stable transgenic mosquitoes
through germline transformation. There are, however, some draw-
backs in these approaches. A serious concern about RNAi is that
dsRNA/siRNA may promote off-target silencing, leading to
ambiguous conclusions of gene function as it relates to microbial
infection [12,13]. Germline transformation is inefficient and time
consuming, and the maintenance of transgenic strains is costly and
laborious [14]. Development of a simple approach to efficiently
express a gene in mosquitoes is, therefore, urgently needed and
will accelerate the study of pathogen-mosquito interactions. We
now report on the efficient introduction of plasmid DNA into
mosquitoes and use this technique to elucidate the role of Ae. aegypti
thioester-containing proteins (AeTEP) in flaviviral infection.
Results
An efficient approach to deliver genes into mosquitoes is a
powerful tool for mosquito genetic studies. We used a GFP-
expressing plasmid, pAc-GFP, which has a Drosophila actin pro-
moter and GFP gene, to optimize the experimental condition. To
transfect the GFP gene into mosquitoes, we directly microinjected
pAc-GFP or empty vector DNA into the thorax of mosquitoes, as
described in a previous study [15]. GFP expression, however,
could not be readily detected either by RT-QPCR (Figure 1a) or
by fluorescence microscopy (data not shown). This suggests that
direct inoculation of DNA is inefficient and that protein expression
is insufficient for functional studies.
In vivo transfection of pAc-GFP plasmid with Cellfectin IIH
A previous study showed that an exogenous gene was
transfected into dissected Ae. aegytpi salivary glands by an in vitro
liposome-based transfection [16]. We therefore reasoned that a
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efficiency into live mosquitoes. Liposome-based reagents are
widely used for DNA transfection into insect cell lines. Cellfectin
IIH [17] and FuGene 6H [18] are common transfection reagents
for cellular studies. We therefore examined whether these reagents
could deliver plasmid DNA into adult female mosquitoes with high
efficiency.
Liposome is potentially harmful to mosquitoes. FuGene 6H was
lethal to Ae. aegypti, as after thoracic inoculation, only 1 out of 120
mosquitoes survived. Cellfectin IIH, however, was well tolerated by
mosquitoes (Figure 1b), suggesting that it may be suitable for in vivo
transfection studies. To evaluate the ability of Cellfectin IIH to
deliver plasmid DNA, we mixed Cellfectin IIH with the pAc-GFP
plasmid and microinjected the liposome-DNA mixture into Ae.
aegypti. Empty DNA vector and pAc-GFP in medium served as
controls. GFP mRNA was quantified by RT-QPCR at various
time points. The empty vector and pAc-GFP alone groups ex-
pressed very little GFP; however, Cellfectin IIH significantly en-
hanced GFP expression (Figure 1a). Consistent with the QPCR
results, GFP protein was dramatically enhanced by Cellfectin IIH
post microinjection (Figure 2a). We then titrated the plasmid DNA
via 2-fold dilutions, and microinjected this material with Cellfectin
Figure 1. Cellfectin IIH enhances GFP mRNA in vivo expression in Ae. aegypti. (a) Cellfectin IIH significantly enhances GFP expression in Ae.
aegypti. 200 ng pAc-GFP and the empty vector DNA were microinjected per mosquito. Total RNA was isolated from whole mosquitoes and the
samples were decontaminated by Dnase I treatment. The GFP expression was determined by SYBR GreenH QPCR, and normalized using Ae. aegypti
actin (AAEL011197). Each dot represents 1 mosquito. The experiment was repeated twice with similar results. (b) Cellfectin IIH does not influence
mosquito survival. Each liposome reagent mixed with vector DNA was microinjected into the mosquito (200 ng DNA each mosquito). The mosquito
survival was recorded at 6 hours after materials inoculation. Control mosquitoes were treated with PBS. The number at the top of bar represents the
number of live mosquitoes/total mosquitoes in a treatment.
doi:10.1371/journal.pone.0022786.g001
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pAc-GFP per mosquito produced substantial GFP expression in
Ae. aegypti.
Anopheles spp. transmit Plasmodium, the etiologic agent of malaria
[7,19]. We therefore extended this approach to An. gambiae, and
assessed whether this method was effective in another mosquito
species that transmits important diseases. Cellfectin IIH also
significantly increased GFP expression in An. gambiae (Figure 2c).
Moreover, the amount of GFP protein was 100–500 folds greater
in An. gambiae than in Ae. aegypti (Figure 2c). In the titration analysis,
GFP expression was dramatically decreased when the inoculated
DNA was less than 50 ng per mosquito (Figure 2d). To determine
the distribution of expression, GFP was assessed in mosquito
tissues by microscopy. Fluorescence was observed in the An.
gambiae salivary glands and midgut. Figure S1 shows fluorescence
at days 3 and 6 post injection in the liposome-DNA treated groups,
confirming that Cellfectin IIH facilitates the in vivo expression of
DNA in mosquitoes.
In vivo overexpression of AeTEP-1 influences flaviviral
infection
The Thioester-containing protein (TEP) gene exists in numerous
mosquito species, and forms a distinct clade of a multigene family.
TEP includes several vertebrate complement domains, and is
considered a complement-like protein in mosquitoes [20]. A TEP
gene from An. gambiae mediates recognition and killing of
Plasmodium berghei ookinetes [21]. In invertebrates, TEPs are a
component of the innate immune system to pathogens. The role of
TEPs in flavivirus infection is, however, unknown. We therefore
determined the role of Ae. aegypti TEP (AeTEP) genes in DENV and
WNV infection by RNA interference, and validated the phenotype
by in vivo overexpression.
We identified 6 TEP homologues from the Ae. aegypti genome
and designated them as AeTEP-1 to AeTEP-6. AeTEPs share 21–
39% amino acid identity with Anopheles TEP-1. Of these 6 genes, 5
AeTEPs were expressed in the adult female Ae. aegypti (Table S1).
AeTEPs genes were silenced in Ae. aegypti by gene-specific dsRNA.
Compared to the mock group, expression of all the AeTEPs was
significantly reduced from days 3 through 9 (Figure S2a, S2b, S2c,
S2d, S2e). WNV and DENV were therefore inoculated into
mosquitoes on day 3 following dsRNA-treatment, and the viral
load on day 6 post-infection was quantified by RT-QPCR. The
viral loads in AeTEP-1 and AeTEP-2 silenced mosquitoes were
enhanced by 2–3 fold when compared with those of mock-treated
mosquitoes (Figure 3 and Figure S3), suggesting that AeTEPs may
play an important role in resistance to flaviviral infection of
Ae. aegypti.
To further confirm the function of AeTEPs in flavivirus
infection, we selected AeTEP-1 and AeTEP-3 for in vivo overex-
pression investigation. Meanwhile, a truncated AeTEP-1 (AeTEP-1-
BstBI) was generated as a control for functional study. These genes
were cloned into pAc5.1/V5-His A vector and the recombinant
plasmids were named as pAc-AeTEP-1, pAc-AeTEP-1-BstBI and
pAc-AeTEP-3 respectively. Then, these genes were expressed in
Figure 2. Cellfectin IIH enhances GFP protein expression in Ae. aegypti. Cellfectin IIH facilitates GFP expression in Ae. aegypti (a) and in An.
gambiae (c). 200 ng plasmids were microinjected into mosquitoes. The GFP protein concentration in whole mosquito lyses was measured by ELISA.
Data are expressed as the mean 6 standard error from 3 independent experiments. Titration of the amount of plasmid DNA influences the GFP
expression in Ae. aegypti (b) and in An. gambiae (d). 2-fold titrated plasmid DNA with Cellfectin IIH was inoculated into mosquitoes. The treated
mosquitoes were sacrificed at 6 days post microinjection and homogenated in tissue lysis buffer. The GFP protein level was determined by ELISA.
Data are expressed as the mean 6 standard error from 3 independent experiments.
doi:10.1371/journal.pone.0022786.g002
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a ,200 kD recombinant protein encoded by the AeTEP-1
(Figure 4a) and ,100 kD proteins by AeTEP-3 and truncated
AeTEP-1-BstBI genes (Figure S4a). Subsequently, these recombi-
nant plasmids were microinjected into mosquitoes with Cellfectin
IIH to assess the efficiency of in vivo over-expression. The same
amount of empty pAc vector or pAc-AeTEP plasmids alone served
as controls. The mosquitoes were collected at various time points
after microinjection to isolate the total RNA for the detection of
AeTEPs. AeTEP-1 (Figure 4b) and AeTEP-3 expression (Figure S4b)
were significantly higher in the Cellfectin IIH transfected groups
than in controls, at all time points. Then, the AeTEPs transfection
mosquitoes were used to elucidate the role in flaviviral infection.
The Cellfectin IIH alone and empty vector inoculated mosquitoes
served as negative controls. Compared to the controls, the DENV
burden was significantly decreased in the AeTEP-1 expressing
group (p,0.0001), but not in the AeTEP-3 or AeTEP-1-BstBI
expressing groups (Figure 4c), suggesting AeTEP-1 has a specific
role against DENV infection. However, the overexpression of
AeTEP-1 did not influence WNV infection of mosquitoes (Figure
S4c), implying that the AeTEP-1 function is ambiguous in WNV
infection. In conclusion, our results demonstrate the usefulness of
this in vivo transfection strategy for functional study of mosquito
genes.
Discussion
Mosquitoes transmit numerous infectious diseases. Develop-
ment of techniques to rapidly manipulate mosquitoes will facilitate
our understanding of the pathogenesis of vector-borne diseases.
Genetic studies on mosquitoes are generally conducted in cell-
culture. These studies provide important information; however,
understanding the pathogenesis of vector-borne microbes requires
in vivo studies. Here, we used a transfection reagent to introduce
plasmid DNA into mosquitoes through thoracic microinjection.
This procedure enabled us to successfully express an important
gene in vivo. Our results demonstrated that the method worked in
both An. gambiae and Ae. aegypti, albeit better in An. gambiae.
However, Cellfectin IIH did not efficiently transfect plasmid DNA
into Ixodes scapularis (data not shown), a tick that transmits diverse
pathogens including the agent of Lyme disease. These data
indicated that different arthropod species has varying sensitivity to
this liposome-based transfection.
In this study, we assessed the antiviral function of the family of
Ae. aegypti complement-like factors using RNAi and in vivo
transfection approaches. The complement system combats viral
infection in mammals [22]. Complement components are asso-
ciated with viral surface proteins during early infection and are
activated to promote the destruction of viral particles and initiate
innate immune responses [23,24]. In flaviviral infection, comple-
ment components can activate B cells, assist in B cell maturation,
and enhance viral neutralization in an antibody-mediated manner
[25]. Recent studies have shown that a complement-like factor,
Thioester-containing protein (TEP) genes, exists in An. gambiae to
mediate parasite killing [21,26]. To determine the role of TEP
genes in flavivirus infection, we identified five expressed TEP
homologues in female Ae.aegypti. Silencing certain AeTEP by RNAi
led to a significant enhancement of WNV and DENV burdens. To
further confirm the role of AeTEPs in flaviviral infection, we chose
AeTEP-1 and AeTEP-3, and also generated an AeTEP-1 truncation,
for in vivo over-expression. Compared to liposome alone and vector
controls, AeTEP-1 expression dramatically decreased the DENV
infection, however, the same phenomenon was not observed in
AeTEP-3 and truncated AeTEP-1-transfected mosquitoes. Togeth-
er with the gene silencing results, we concluded AeTEP-1 plays a
role in resistance to DENV infection of mosquitoes. Ae. aegypti is a
primary mosquito species for DENV infection and transmission in
nature. Similar to mammals, mosquitoes also evolve specific
defense mechanism, including complement-like factors, to effi-
ciently control DENV infection. AeTEP-1 silencing also showed a
strong resistance in WNV infection. However, the in vivo trans-
fection of AeTEP-1 did not elucidate a similar phenomenon,
suggesting AeTEPs-based resistance system is important, but not
essential in WNV infection.
Figure 3. Silencing AeTEPs enhances DENV infection. AeTEPs were silenced by dsRNA treatment. The mock group was treated with the same
amount of GFP dsRNA. The DENV burden was examined at 6 days post-infection. 10 MID50 DENV was used to challenge mosquitoes. The viral load
was determined by TaqmanH QPCR, and normalized by Ae. aegypti actin. Each dot represents 1 mosquito. The Mann-Whitney test was used for
statistic analysis. The horizontal lines depict the medians of result. The result shown was combined with 3 independent experiments.
doi:10.1371/journal.pone.0022786.g003
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an exogenous gene in mosquitoes in vivo. The technique was
validated by assessing the importance of an Ae. aegypti TEP gene in
flaviviral infection. This method is potentially useful in mosquito-
pathogen interaction studies in many ways: validation of RNAi
silencing results, in vivo biochemical studies and mosquito genetic
investigations. This approach should facilitate an understanding of
the interaction between mosquitoes and the infectious agents that
they transmit.
Materials and Methods
Mosquitoes, cells and viruses
Ae. aegypti and An. gambiae mosquitoes were maintained in a
sugar solution at 27uC and 80% humidity according to standard
rearing procedures [27,28]. The Aedes albopictus C6/36 cell line was
grown at 30uC in minimal essential medium (MEM) for WNV and
DENV production. The Drosophila melanogaster S2 cell line was
cultured in Schneider’s Medium. All mediums were supplemented
with 10% heat-inactivated fetal bovine serum, 1% L-glutamine,
100 IU of penicillin and streptomycin per ml. WNV strain 2741,
which is identical at the protein level to the NY99 strain [29], and
DENV-2 (DENV New Guinea C strain) were used in this study.
The viruses for in vivo experiments were titrated in mosquitoes
through thoracic microinjection. The procedure was described in
a previous study [11].
DNA construction
GFP gene was amplified from pCAG-GFP plasmid and
subcloned into pAc5.1/V5-His A vector (Invitrogen, Cat. No#
V411020). The recombinant plasmid was designated as pAc-GFP
in this study. The cloning primers for pAc-GFP were: Forward,
GCTACAGAATTCATGGTGAGCAAGGGCGAGGAG; Reverse,
GCTACACTCGAGCTTGTACAGCTCGTCCATGC. Ae. aegypti
TEP-1 and TEP-3, including a signal peptide gene, was produced
from a cDNA library and cloned into pAc5.1/V5-His A. The
recombinant plasmid was named as pAc-AeTEP-1 and pAc-
AeTEP-3 respectively. The cloning primers for pAc-AeTEP-1 were:
Forward, TCTGAGTTTAAACATGACCCGTCGGTGGCAT-
CC; Reverse, TCTGACCATGGCTAATCGTTCCAAAAGAT-
CC. The cloning primers for pAc-AeTEP-3 were: Forward,
GTACTCGGTACCATGTCCTACTTTGTCACAAAC; Reverse,
Figure 4. In vivo overexpression of AeTEP-1 impairs DENV infection. (a) AeTEP-1 expression in S2 cells. pAc-AeTEP-1 expressed a ,200 KD
recombinant protein in drosophila S2 cells. AeTEP-1 was detected with a V5-HRP mAb. The mock control was the empty vector transfected S2 cells. (b)
Cellfectin IIH facilitates AeTEP-1 expression in Ae. aegypti at 3 days (i), 6 days (ii) and 12 days (iii) post microinjection. Controls are the mosquitoes
inoculated with empty pAc vector or only pAc-AeTEP-1 plasmid DNA in medium. The mRNA level of AeTEP-1 was determined by SYBR GreenH QPCR,
and normalized using Ae. aegypti actin. The experiment was repeated 3 times with similar results. (c) Overexpression of AeTEP-1 significantly
decreased DENV burden. The viral load was determined by TaqmanH QPCR, and normalized by Ae. aegypti actin. The result shown was pooled from 3
independent experiments. (b and c) Each dot represents 1 mosquito. The Mann-Whitney test was used for statistical analysis.
doi:10.1371/journal.pone.0022786.g004
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cated AeTEP-1 in pAc vector, pAc-AeTEP-1-BstBI, was constructed
by BstBI restriction enzyme treatment. The BstBI digestion in pAc-
AeTEP-1 depletes the 2640 bp-5382 bp region of AeTEP-1, leading
to an in-frame truncation.
Cellfectin IIH in vivo transfection
Cellfectin IIH (Invitrogen, Cat No# 10362-100) was mixed with S2
Schneider’s medium (serum/antibiotics-free) as 1:1 ratio (vol/vol). The
mixture was kept at room temperature for 10 min. 2 vols of the diluted
plasmid DNA were then combined with diluted Cellfectin IIH and
gently mixed. The transfection mixture was further incubated for
30 min at room temperature prior to thoracic microinjection.
Microinjection
dsRNA synthesis was performed as described previously [30].
The primers are shown in the Table S1. Plasmid DNA was
isolated by an EndoFree Plasmid Maxi Kit (Qiagen, Cat. No#
12362). For thoracic microinjection, 1 week old adult female
mosquitoes were kept on ice for 15 min, and then transferred to a
cold tray to receive a systemic injection of dsRNA or plasmid
DNA into the hemocoele. In the gene silencing studies, 2 mgo f
dsRNA/300 nl in PBS was microinjected into the thorax of each
mosquito. Following a 3-day recovery period, the mosquitoes were
microinjected with WNV or DENV 10 M.I.D50/300 nl (50%
Mosquito Infective Dose) [11] for functional studies. In the in vivo
transfection, 200 ng plasmid DNA/300 nl mixture was inoculated
into each mosquito. The mosquitoes were further challenged
by 10 M.I.D50 of DENV and WNV at day 6 following the
inoculation of the transfection mixture.
Quantitative PCR
The specific RNAs of the WNV-E gene, DENV-E gene and
AeTEPs gene were quantified by RT-QPCR. The primers and
probes for WNV-E and DENV-E gene were described previously
[11]. The primers for AeTEPs are shown in Table S1. The amount
of viruses were normalized using Ae. aegypti actin (AAEL011197).
ELISA
Three mosquitoes were pooled together and homogenated in
300 ml T-PER tissue protein extraction buffer (Thermo Scientific,
Cat. No# 78510) with a Pestle Grinder System (FisherSci, Cat.
No# 03-392-106). The samples were centrifuged for 10 min at
4uC and the supernatant were collected for ELISA assay. The
experimental details are described in the product manual of GFP
ELISA kit (Cell Biolabs, Cat. No# AKR-121).
Isolation and imaging of mosquito tissues
Salivary glands and midgut were dissected as previously
described [31]. Tissues were isolated, placed on sialylated slides
(PGC Scientific, Gaithersburg, MD), washed in PBS, and fixed in
4% PFA at 37uC for 1 hr. Slides were imaged with a Single-Track
mode of a Zeiss LSM 510 meta confocal microscope.
Supporting Information
Figure S1 GFP fluorescence in mosquito tissues. The
tissues were dissected at day 3 and day 6 post microinjection. The
fluorescence was detected by confocal microscopy. (a) salivary
glands; (b) midgut. Images were examined using a Zeiss LSM 510
meta confocal 106objective lens.
(TIF)
Figure S2 AeTEPs RNAi efficiency. The mock group was
treated with the same amount of GFP dsRNA. AeTEPs-dsRNA or
GFP-dsRNA treated mosquitoes were sacrificed to isolate total
RNA at 3 days and 9 days post-inoculation. mRNA of AeTEPs was
determined by SYBR GreenH QPCR, and normalized using Ae.
aegypti actin.( a) AeTEP-1;( b) AeTEP-2;( c) AeTEP-3;( d) AeTEP-4;
(e) AeTEP-5. Each dot represents 1 mosquito. The Mann-Whitney
test was used for statistical analysis.
(TIF)
Figure S3 Silencing AeTEPs enhances WNV infection.
AeTEP genes were respectively knocked down by dsRNA
treatment. The mock group was treated with the same amount
of GFP dsRNA. At 3 days post-silencing, 10 MID50 WNV was
microinjected into mosquitoes. The WNV burden was examined
at 6 days post-infection. The viral load was determined by
TaqmanH QPCR, and normalized by Ae. aegypti actin. Each dot
represents 1 mosquito. The Mann-Whitney test was used for
statistical analysis. The horizontal line depicts the medians of the
result. The result shown is the combination of 3 independent
experiments.
(TIF)
Figure S4 AeTEP-3 and AeTEP-1-BstBI expression and
the role of AeTEPs in WNV infection. (a) AeTEP-3 and
AeTEP-1-BstB1 expression in S2 cells. AeTEPs were detected with
a V5-HRP mAb. The mock control was the vector transfected S2
cells. (b) Cellfectin IIH facilitates AeTEP-3 expression in Ae. aegypti
at 6 days (i) and 12 days (ii) post microinjection. Controls are the
mosquitoes inoculated with empty pAc vector or only pAc-AeTEP-
3 plasmid DNA in medium. mRNA of AeTEP-3 was determined
by SYBR GreenH QPCR, and normalized using Ae. aegypti actin.
The experiment was repeated twice with similar results. (c) The
AeTEPs in vivo expression in WNV infection. The viral load was
determined by TaqmanH QPCR, and normalized by Ae. aegypti
actin. Each dot represents 1 mosquito. Statistical analysis used the
Mann-Whitney test.
(TIF)
Table S1 AeTEP family in Ae. aegypti.
(DOC)
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